TNDM

23.13

1.36% -0.32

Pre-mercato: 23.28 0.15 +0.65%

Tandem Diabetes Care Inc (TNDM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TNDM Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$23.45

Aprire:

$23.56

Volume 24 ore:

1.44M

Relative Volume:

0.81

Capitalizzazione di mercato:

$1.42B

Reddito:

$796.00M

Utile/perdita netta:

$-136.49M

Rapporto P/E:

-11.07

EPS:

-2.09

Flusso di cassa netto:

$-64.24M

1 W Prestazione:

+8.49%

1M Prestazione:

+35.58%

6M Prestazione:

-22.04%

1 anno Prestazione:

-47.35%

Intervallo 1D:

$23.05

$23.56

Intervallo di 1 settimana:

$21.28

$24.00

Portata 52W:

$15.75

$53.69

Tandem Diabetes Care Inc Stock (TNDM) Company Profile

Nome

Tandem Diabetes Care Inc

Settore

Healthcare (1148)

Industria

Medical Devices (153)

Telefono

858-366-6900

Indirizzo

12400 HIGH BLUFF DRIVE, San Diego, CA

Dipendente

2,650

Cinguettio

@tandemdiabetes

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

TNDM's Discussions on Twitter

Confronta TNDM con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TNDM Tandem Diabetes Care Inc	23.13	1.42B	796.00M	-136.49M	-64.24M	-2.09
ABT Abbott Laboratories	129.05	231.50B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.95	154.04B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	387.53	144.27B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	85.11	105.58B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	75.50	43.95B	5.54B	4.18B	623.10M	7.00

Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-04-10	Iniziato	Mizuho	Neutral
2025-03-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2025-03-04	Downgrade	Citigroup	Buy → Neutral
2025-03-03	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-02-28	Downgrade	Bernstein	Outperform → Mkt Perform
2024-12-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-11-06	Iniziato	Bernstein	Outperform
2024-10-04	Iniziato	Goldman	Neutral
2024-10-02	Iniziato	RBC Capital Mkts	Outperform
2024-08-22	Iniziato	Morgan Stanley	Equal-Weight
2024-08-08	Iniziato	Canaccord Genuity	Buy
2024-05-30	Iniziato	Redburn Atlantic	Buy
2024-05-22	Aggiornamento	Citigroup	Neutral → Buy
2024-04-29	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-04-25	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-03-26	Aggiornamento	Stifel	Hold → Buy
2023-08-04	Downgrade	Citigroup	Buy → Neutral
2023-05-05	Downgrade	BofA Securities	Neutral → Underperform
2023-04-24	Downgrade	Raymond James	Outperform → Mkt Perform
2023-03-29	Iniziato	UBS	Neutral
2023-01-26	Iniziato	Wolfe Research	Peer Perform
2022-11-15	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Buy
2022-08-09	Downgrade	Wells Fargo	Overweight → Underweight
2022-03-02	Ripresa	BofA Securities	Neutral
2022-01-19	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2021-07-21	Ripresa	Cowen	Outperform
2021-05-25	Iniziato	Barclays	Underweight
2020-12-15	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-08-20	Iniziato	Wells Fargo	Overweight
2020-07-31	Aggiornamento	Guggenheim	Neutral → Buy
2020-07-06	Aggiornamento	Citigroup	Neutral → Buy
2020-06-18	Reiterato	Raymond James	Outperform
2020-04-24	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-03-23	Downgrade	Guggenheim	Buy → Neutral
2020-03-05	Iniziato	Citigroup	Neutral
2020-02-06	Iniziato	Raymond James	Outperform
2020-02-04	Downgrade	Robert W. Baird	Outperform → Neutral
2019-10-18	Iniziato	Guggenheim	Buy
2019-10-04	Aggiornamento	UBS	Neutral → Buy
2019-05-17	Reiterato	BofA/Merrill	Neutral
2019-05-13	Iniziato	SVB Leerink	Outperform
2019-03-08	Iniziato	BMO Capital Markets	Outperform
2019-03-05	Reiterato	BofA/Merrill	Neutral
2019-02-27	Reiterato	Lake Street	Buy
2018-11-21	Aggiornamento	Robert W. Baird	Neutral → Outperform
2018-09-26	Reiterato	Dougherty & Company	Buy
2018-09-26	Reiterato	Piper Jaffray	Overweight

Mostra tutto

Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie

May 13, 2025

Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set - MassDevice

May 13, 2025

May 12, 2025

Tandem Diabetes Care gets FDA clearance for new set By Investing.com - Investing.com Nigeria

May 12, 2025

Tandem Diabetes Care gets FDA clearance for new set - Investing.com

May 12, 2025

Tandem's Initial Growth Spurt From the Launch of Mobi Should Moderate in the Near Term - Morningstar

May 12, 2025

May 10, 2025

Investor Network: Tandem Diabetes Care, Inc. to Host Earnings Call - ACCESS Newswire

May 10, 2025

May 09, 2025

INVESTOR ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – TNDM - ACCESS Newswire

May 09, 2025

INVESTOR ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineTNDM - ACCESS Newswire

May 09, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Tandem Diabetes Care, Inc.(TNDM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

May 09, 2025

INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023TNDM - ACCESS Newswire

May 09, 2025

INVESTOR ALERT: Levi & Korsinsky Reminds Tandem Diabetes Care, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 7, 2023 – TNDM - ACCESS Newswire

May 09, 2025

May 07, 2025

Earnings Release: Here's Why Analysts Cut Their Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Price Target To US$35.52 - simplywall.st

May 03, 2025

Tandem Diabetes jumps as overseas sales drive Q1 beat - MSN

May 03, 2025

May 02, 2025